Published in Cancer Weekly, August 2nd, 2005
The study aims to provide greater insight into the genetic contribution to these three chronic diseases, each a major cause of death, disability and frailty among postmenopausal women of all races and socioeconomic backgrounds, and to relate these findings to the effects of estrogen plus progestin (E+P) therapy.
WHI, with funding support from the U.S....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.